Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3403309
Max Phase: Preclinical
Molecular Formula: C36H60N6O8
Molecular Weight: 704.91
Molecule Type: Small molecule
Associated Items:
ID: ALA3403309
Max Phase: Preclinical
Molecular Formula: C36H60N6O8
Molecular Weight: 704.91
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)C(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)COC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C
Standard InChI: InChI=1S/C36H60N6O8/c1-11-42(12-2)35(47)29(19-25-13-15-26(49-10)16-14-25)40-33(45)28(17-21(3)4)39-34(46)31(23(7)8)41-32(44)27(37)20-50-36(48)30(18-22(5)6)38-24(9)43/h13-16,21-23,27-31H,11-12,17-20,37H2,1-10H3,(H,38,43)(H,39,46)(H,40,45)(H,41,44)/t27-,28-,29-,30-,31-/m0/s1
Standard InChI Key: KLCOQPJQOMWJDH-QKUYTOGTSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 704.91 | Molecular Weight (Monoisotopic): 704.4473 | AlogP: 1.68 | #Rotatable Bonds: 21 |
Polar Surface Area: 198.26 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 14 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.78 | CX Basic pKa: 7.22 | CX LogP: 1.92 | CX LogD: 1.70 |
Aromatic Rings: 1 | Heavy Atoms: 50 | QED Weighted: 0.12 | Np Likeness Score: -0.18 |
1. Zhen XL, Yin WH, Tian X, Ma ZJ, Fan SM, Han JR, Liu S.. (2015) Synthesis and biological evaluation of open-chain analogs of cyclic peptides as inhibitors of cellular Shp2 activity., 23 (10): [PMID:25865131] [10.1016/j.bmc.2015.03.035] |
Source(1):